Rajarsi Mandal Selected Research

Rajarsi Mandal Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2016
8	Squamous Cell Carcinoma of Head and Neck 12/2023 - 10/2016
6	Head and Neck Neoplasms (Head and Neck Cancer) 11/2023 - 01/2019
3	Ischemia 10/2007 - 06/2006
2	Hypopharyngeal Neoplasms 01/2023 - 10/2019
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2023 - 01/2022
2	Hemorrhage 01/2017 - 01/2016
2	Infarction (Infarctions) 10/2007 - 09/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006 - 06/2006
1	Hypersensitivity (Allergy) 12/2023
1	Chronic Pain 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Pain (Aches) 01/2022
1	Hematoma 01/2020
1	Turcot syndrome 01/2019
1	Microsatellite Instability 01/2019
1	Melanoma (Melanoma, Malignant) 11/2017
1	Tinnitus 05/2017
1	Postoperative Hemorrhage 01/2017
1	Edema (Dropsy) 03/2015
1	Sinusitis 04/2012
1	Rhinosinusitis 04/2012
1	Myocardial Reperfusion Injury 09/2006
1	Reperfusion Injury 06/2006
1	Chest Pain (Chest Pains) 06/2006
1	Myocardial Infarction 06/2006
1	Angina Pectoris 06/2006

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 12/2023 - 10/2016
2	AntibodiesIBA 11/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2021
2	AntigensIBA 01/2019 - 01/2019
2	pyrrolineIBA 10/2007 - 06/2006
2	AntioxidantsIBA 10/2007 - 06/2006
2	Krebs-Henseleit solutionIBA 09/2006 - 06/2006
1	Indicators and Reagents (Reagents)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	MMEIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Estrogen Receptor alphaIBA 10/2021
1	B7-H1 AntigenIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	LigandsIBA 01/2021
1	NivolumabIBA 11/2017
1	IpilimumabIBA 11/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 05/2017
1	AnticoagulantsIBA 01/2017
1	potassium titanylphosphateIBA 03/2015
1	MacrolidesIBA 04/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2012
1	Verapamil (Calan)FDA LinkGeneric 10/2007
1	CalciumIBA 10/2007
1	1- hydroxy- 2,2,5,5- tetramethyl- 2,5- diydro- 1H- pyrrole- 3- carboxylic acid (2- (3,4- dimethoxyphenyl)- 5- ((2- (3,4- dimethoxyphenyl)ethyl)methylamino)- 2- isopropylpentyl)amideIBA 10/2007
1	Uric Acid (Urate)IBA 09/2006
1	tempolIBA 09/2006
1	nitroaspirinIBA 09/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2006
1	p38 Mitogen-Activated Protein KinasesIBA 06/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 06/2006
1	Trimetazidine (Vastarel)IBA 06/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2006

Therapy/Procedure

11	Immunotherapy 12/2023 - 01/2016
6	Therapeutics 01/2019 - 04/2012
3	Neck Dissection (Radical Neck Dissection) 01/2023 - 01/2022
2	Laryngectomy 01/2023 - 10/2019
2	Thyroidectomy 01/2022 - 01/2020
2	Ligation 01/2017 - 01/2016
1	Pain Management 01/2022
1	Free Tissue Flaps 01/2022
1	Analgesia 01/2022
1	Length of Stay 01/2020
1	Radiotherapy 01/2019
1	Adjuvant Chemoradiotherapy 01/2016
1	Robotic Surgical Procedures 01/2016
1	Lasers (Laser) 03/2015
1	Solid-State Lasers 03/2015